Bafna Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	20.25	34.33	13.96	78.09	1.73
Cash & Short-Term Investments	20.25	34.33	13.96	78.09	1.73
Cash Growth	-41.02%	145.90%	-82.12%	4414.10%	-90.41%
Accounts Receivable	439.29	401.74	453.95	411.49	147.8
Other Receivables	1.06	-	-	-	-
Receivables	441.13	401.97	454.77	412.03	148.76
Inventory	289.03	280.86	296.42	222.2	202.81
Prepaid Expenses	-	5.21	4.61	3.73	-
Other Current Assets	146.12	139.43	167.95	157.07	155.5
Total Current Assets	896.52	861.79	937.71	873.12	508.8
Property, Plant & Equipment	849.24	660.93	507.07	402.3	388.46
Long-Term Investments	0.01	0.01	-	-	-
Other Intangible Assets	-	-	17.7	15	-
Other Long-Term Assets	9.56	8.07	14.34	5.42	4.19
Total Assets	1,755	1,531	1,477	1,296	901.45
Accounts Payable	312.86	309.45	354.22	284.61	124.05
Accrued Expenses	-	32.22	30.19	27.38	33.39
Short-Term Debt	196.51	85.7	100.11	119.09	45.92
Current Portion of Long-Term Debt	-	56	36.25	25.81	11.51
Current Income Taxes Payable	-	-	-	0.81	0.9
Current Unearned Revenue	3.26	1.66	0.99	0.99	0.66
Other Current Liabilities	59.26	33.49	19.07	6.07	3.71
Total Current Liabilities	571.9	518.52	540.83	464.76	220.13
Long-Term Debt	177.82	140.29	107.53	84.33	53.17
Long-Term Unearned Revenue	39.95	19.14	16.15	12.19	8.51
Other Long-Term Liabilities	4.16	4.78	3.92	-	-
Total Liabilities	793.83	682.73	668.43	561.29	281.81
Common Stock	236.56	236.56	236.56	236.56	236.56
Additional Paid-In Capital	-	753.77	753.77	753.77	753.77
Retained Earnings	-	-412.08	-451.75	-525.6	-640.51
Comprehensive Income & Other	724.93	269.81	269.81	269.81	269.81
Total Common Equity	961.5	848.07	808.39	734.55	619.64
Shareholders' Equity	961.5	848.07	808.39	734.55	619.64
Total Liabilities & Equity	1,755	1,531	1,477	1,296	901.45
Total Debt	374.33	281.99	243.89	229.24	110.59
Net Cash (Debt)	-354.09	-247.66	-229.93	-151.15	-108.86
Net Cash Per Share	-14.96	-10.47	-9.72	-6.39	-4.60
Filing Date Shares Outstanding	23.7	23.66	23.66	23.66	23.66
Total Common Shares Outstanding	23.7	23.66	23.66	23.66	23.66
Working Capital	324.63	343.27	396.88	408.35	288.67
Book Value Per Share	40.57	35.85	34.17	31.05	26.19
Tangible Book Value	961.5	848.07	790.69	719.55	619.64
Tangible Book Value Per Share	40.57	35.85	33.42	30.42	26.19
Land	-	1.93	1.93	1.93	1.93
Buildings	-	275.1	251.51	250.78	245.71
Machinery	-	778.25	741.42	693.86	631.75
Construction In Progress	-	73.13	104.96	-	-